6 studies found for: "Membranoproliferative glomerulonephritis type 2"
Sulodexide Treatment in Patients With Dense Deposit Disease
Eculizumab Therapy for Dense Deposit Disease and C3 Nephropathy
Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease
TP10 Use in Patients With C3 Glomerulopathy (C3G)
Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721
|6||Not yet recruiting||
A Proof-of-Mechanism Study to Determine the Effect of ACH-0144471 on C3 Levels in Patients With C3G or IC-MPGN
† Study has passed its completion date and status has not been verified in more than two years.